Bonus Sessions at ACG Annual Meeting

ACG Annual Scientific Meeting Optional Bonus Sessions

Add this optional package to your Annual Scientific Meeting registration for even more first-class education that provides an additional 16.75 hours of CME/MOC credit! This add-on provides access to dozens of recorded presentations and slides from 16 Bonus Sessions. These Bonus Sessions are prerecorded narrations by faculty of their presentation slides, and will be available to watch on-demand on the ACG 2026 Conference Platform, from October until March 31, 2027. (You must register for the Annual Scientific Meeting in order to purchase the optional Annual Scientific Meeting Bonus Sessions package. Both in-person and virtual registrants can purchase this add-on package.)

In-Person "GI Ignite – Meet the Experts" Breakfast Sessions

Join ACG expert faculty at the fun and fast-paced “GI Ignite - Meet the Experts” Breakfast Sessions! Offered on Monday and Tuesday mornings for in-person attendees, these small setting events allow for heightened interaction with presenters. The first half of each 60-minute session consists of 6 expert faculty providing brief summaries and clinical pearls from their Bonus Session presentations. The remaining time will be devoted to Q&A and interaction with the faculty. Coffee and continental breakfast will be provided. These in-person sessions are open to all attendees, but access to the recorded lectures and slides that will be discussed requires purchase of the ACG Annual Meeting Bonus Sessions package.

Monday, October 12, 2026 | 6:45 AM - 7:45 AM (CENTRAL TIME)
GI IGNITE SESSION 1
Moderator: Vonda G. Reeves, MD, MBA, FACG
Bonus Session A: Getting the Band Back Together: Interdisciplinary Approach to Managing DGBI
  • How APPs Enhance Your DGBI Practice
    Amy L. Stewart, FNP-C
    Discuss the importance of integrative care in disorders of gut-brain interaction.
  • Behavioral Therapy for DGBI
    Megan E. Riehl, PsyD
    Define appropriate behavioral interventions for comprehensive management of disorders of gut-brain interaction.
  • Dietary Therapies for DGBI
    Nancee Jaffe, RD, MS
    Explain appropriate nutritional interventions for comprehensive management of disorders of gut-brain interaction.
Bonus Session B: Advanced Practice Providers in GI: Driving Quality, Access, and Innovation in Modern GI Care
  • From Access to Excellence: How APPs Expand Capacity and Improve GI Outcomes
    Kristin Marcous, PA-C
    Discuss how adding APPs to clinical practice can address workplace shortages and improve clinical outcomes (including for sub-specialty clinics).
  • Building High-Functioning GI Teams: Integrating APPs Across Academic and Community Practices
    Jessica E. Crimaldi, MSN, AGNP-C
    Describe best practices for onboarding and optimization of GI APPs across diverse practice settings.
  • Beyond the Clinic: APP Leadership in Research, Education, and Program Development
    Meggin Sabatino, DNP, FNP-BC
    Recognize the expanding role of GI APPs in modern GI practice, including their participation in leadership, clinical research, program development, and GI sustainability.
GI IGNITE SESSION 2
Moderator: A. Sidney Barritt, IV, MD, MSCR, FACG
Bonus Session C: Liver Disease in Pregnancy: Practical Management Through Cases
  • Case 1: Incidentaloma in Pregnancy
    Bilal Hameed, MD
    Identify and evaluate common hepatic incidentalomas detected during pregnancy, and the indications for further work-up or intervention.
  • Case 2: Viral Hepatitis in Pregnancy
    Tatyana Kushner, MD
    Assess management of viral hepatitis (HBV, HCV) during pregnancy, incorporating current guideline recommendations for maternal treatment and prevention of vertical transmission.
  • Case 3: Cirrhosis Management in Pregnancy
    Nancy S. Reau, MD, FACG
    Apply evidence-based strategies for the management of cirrhosis in pregnancy, including risk stratification, monitoring for maternal and fetal complications, and coordination of multidisciplinary care.
Bonus Session D: Should I Order a Liver Biopsy? Challenges for the Gastroenterologist
  • TikTok Hepatitis: Popular Supplements for MASH and Their Effects on the Liver
    A. Sidney Barritt, IV, MD, MSCR, FACG
    Identify commonly used supplements and their possible hepatotoxic or beneficial effects on the liver.
  • IBD Hepatopathy: When Biopsy Is Needed
    Maryln J. Mayo, MD, FACG
    Recognize the role of liver biopsy in the care of patients with IBD to better differentiate drug-induced liver issues and autoimmune, metabolic, or biliary disorders.
  • Immunotherapy Hepatitis: When Do You Stop the Cancer Therapy?
    Anusha S. Thomas, MD
    Develop strategies for managing hepatitis and liver-related complications for immunotherapy-induced liver disease in patients with malignancy.
GI IGNITE SESSION 3
Moderator: Jonathan A. Leighton, MD, MACG
Bonus Session E: When Cancer Blocks the Way: Contemporary Approaches to Malignant GI Obstruction
  • Esophageal Malignant Obstruction
    Thomas J. Tielleman, MD
    Outline endoscopic and non-endoscopic strategies for malignant esophageal obstruction based on tumor characteristics, patient prognosis, and goals of care.
  • Colonic Malignant Obstruction
    Phillip S. Ge, MD
    Evaluate the role of endoscopic colonic stenting for palliation and as a bridge to surgery in malignant obstruction.
  • Gastric Outlet Obstruction
    Mouen A. Khashab, MD
    Compare contemporary endoscopic and surgical options for malignant gastric outlet obstruction to guide individualized management decisions.
  • Biliary Obstruction
    Uzma D. Siddiqui, MD, FACG
    Discuss appropriate biliary drainage strategy in malignant obstruction using ERCP-, EUS-, or percutaneous-based approaches.
Bonus Session F: Challenging GI Consults
  • Obscure GI Bleeding
    Jonathan A. Leighton, MD, MACG
    Identify diagnostic and management strategies for obscure gastrointestinal bleeding, including optimal timing and selection of endoscopic and non-endoscopic management.
  • When Your Pregnant Patient Needs Endoscopy
    Shivangi T. Kothari, MD, FACG
    Discuss when endoscopy is indicated during pregnancy, and how to minimize maternal and fetal risk through appropriate procedural planning and sedation strategies.
  • When Not to Scope: Shared Decision-Making
    Lawrence J. Brandt, MD, MACG
    Recognize clinical scenarios in which endoscopy may offer limited benefit, and incorporate shared decision-making to align care with patient values and goals of care.
  • Troubleshooting Enteral Tubes
    Michelle L. Hughes, MD, FACG
    Identify common causes of enteral tube dysfunction and safe, stepwise approaches to evaluation and management.
GI IGNITE SESSION 4
Moderator: Millie D. Long, MD, MPH, FACG
Bonus Session G: What’s New, What’s Next: The Evolving UC Therapeutic Landscape
  • JAK Inhibitors: When and How?
    Marla C. Dubinsky, MD
    Explore appropriate clinical scenarios for initiating JAK inhibitors and key considerations for their use.
  • Selecting Selective IL-23 Inhibitors
    Raymond K. Cross, MD, MS, FACG
    Discuss the evolving landscape of interleukin inhibitors in the treatment of ulcerative colitis.
  • What’s Next in the UC Pipeline? TL1A Inhibition, microRNA, and Emerging Combination Strategies
    Corey A. Siegel, MD, MS
    Describe emerging therapies in the treatment pipeline for ulcerative colitis.
Bonus Session H: Beyond Biologics: Expanding the Scope of Modern IBD Care
  • Cardiovascular Disease in IBD: Is It Time for Routine Screening?
    Millie D. Long, MD, MPH, FACG
    Review the evidence linking IBD to increased cardiovascular risk and discuss whether routine screening should be integrated into standard IBD care.
  • Integrative and Functional Medicine in IBD
    Dawn B. Beaulieu, MD, FACG
    Summarize current evidence for integrative and functional medicine in IBD and provide a practical framework for counseling patients.
  • Psychosocial Interventions in IBD: An Essential Part of Optimizing Patient Outcomes
    Sara N. Horst, MD, MPH, FACG
    Examine the impact of psychosocial factors on IBD outcomes and discuss incorporating mental health care into comprehensive IBD management.
Tuesday, October 13, 2026 | 7:15 AM - 8:15 AM (CENTRAL TIME)
GI IGNITE SESSION 5
Moderator: Dayna S. Early, MD, FACG
Bonus Session I: The Modern-Day GI Practice
  • From Differences to Strengths: Generational Diversity in the GI Workforce
    Amy S. Oxentenko, MD, MACG
    Describe how different generational cohorts within the gastroenterology workforce bring distinct values and work approaches that, when understood and leveraged, can enhance team collaboration, patient care, and organizational effectiveness.
  • How Digital Tools Can Save You an Hour a Day in Your GI Practice
    Jami A. Kinnucan, MD, FACG
    Demonstrate practical applications of digital tools that can streamline administrative tasks, enhance clinical decision-making, and optimize workflow efficiency in GI practice.
  • Demystifying Private Equity in Gastroenterology
    Harish K. Gagneja, MD, MACG
    Explain why PE targets GI, what the valuation drivers are, which physicians gain vs lose, long-term income vs short-term liquidity, and case examples of good and bad deals.
Bonus Session J: Endoscopy Unit Economics and Efficiency
  • From Referral to Scope: Closing the Gaps in Open Access Endoscopy
    Richard S. Tilson, MD
    Describe how to improve throughput and maximize productivity and profitability in open access endoscopy, including pre-op and post-op care, block time utilization, and turnover time benchmarks.
  • Staff Smarter, Scope Better: Reimagining GI Lab Models
    V. Raman Muthusamy, MD, MAS, FACG
    Discuss various staffing models in endoscopy, including staffing ratios (nurses, techs, nurse assistants) for pre-op, intra-op, and post-op, along with scope inventory and repair costs in various endoscopy settings (ASC, HOPD, hospital).
  • Sedation Precision: Tailoring Comfort and Safety in Endoscopy
    Dayna S. Early, MD, FACG
    Explore various anesthesia models (MDA, CRNA), general anesthesia indications, interference with medications (e.g., anticoagulants, GLP1’s, etc.), and comorbidities (recent cardiac events, dialysis, etc.).
GI IGNITE SESSION 6
Moderator: Judy A. Trieu, MD, MPH
Bonus Session K: Holy Moly, That’s a Big Polyp: Now What?
  • Classifying Advanced Colon Polyps
    Carol A. Burke, MD, MACG
    Describe key histologic types, morphological features, and classification systems for large polyps.
  • Tackling Large Polyps: EMR, ESD, and Beyond…
    Mohammad Bilal, MD, FACG
    Identify the appropriate endoscopic resection technique (EMR, ESD, or alternative approaches) for large colorectal polyps based on lesion characteristics.
  • Complications of Endoscopic Resection
    Judy A. Trieu, MD, MPH
    Implement evidence-based strategies for prevention and management of bleeding, perforation, polypectomy syndrome, and incomplete resection of large polyps to optimize patient safety and clinical outcomes.
Bonus Session L: Everyday Colonoscopy Pearls
  • Do’s and Don’ts With Difficult Colonoscopy
    Ashley L. Faulx, MD, FACG
    Apply evidence-based techniques and avoid common pitfalls in difficult colonoscopy to improve cecal intubation rates, procedural efficiency, and patient safety.
  • IBD Colonoscopy Quality Metrics in 2026
    Jean-Paul Achkar, MD, FACG
    Identify and apply current colonoscopy quality metrics to improve overall procedural quality and optimize dysplasia detection for patients with IBD.
  • Leveraging AI in Colonoscopy
    Nasim Parsa, MD
    Integrate AI-assisted technologies (i.e., CADe, CADx) into colonoscopy practice to enhance polyp detection, procedural quality, and clinical decision-making.
GI IGNITE SESSION 7
Moderator: Mary E. Rinella, MD, FACG
Bonus Session M: Which Management Strategy Is Best for This Patient With MASLD?
  • Managing a Patient With MASLD and IBD
    Mary E. Rinella, MD, FACG
    Develop individualized management strategies for patients with MASLD, comorbid conditions, and competing clinical priorities.
  • Managing a Patient With MASLD With Positive Autoantibodies
    Monica A. Tincopa, MD
    Interpret autoimmune serologies and other laboratory abnormalities in the context of MASLD and mixed-etiology liver disease.
  • Managing a Patient With MetALD on a GLP-1A
    Manal F. Abdelmalek, MD, MPH, FACG (Mayo)
    Recognize common and uncommon clinical scenarios in which MASLD coexists with immune-mediated liver disease, alcohol use, or exposure to potentially hepatotoxic medications.
Bonus Session N: Bariatric Care in 2026: Case-Based Decisions Across BMI, Failure, and Malnutrition
  • BMI-Driven First-Line Therapy: “What Should Be Done First?”
    Pichamol Jirapinyo, MD, MPH, FACG
    Select and apply optimal bariatric strategies based on patient BMI, anatomy, and complications.
  • Failed and Botched Bariatric Cases: “Endoscopy First or Surgery First?”
    Shailendra Singh, MD
    Select and apply optimal bariatric strategies based on patient BMI, anatomy, and complications.
  • The Malnourished Post-Bariatric Patient: “Weight Loss Has Gone Too Far”
    Ahmed M. Dirweesh, MD
    Select and apply optimal bariatric strategies based on patient BMI, anatomy, and complications.
GI IGNITE SESSION 8
Moderator: Shannon Chang, MD, FACG
Bonus Session O: Cutting Through Complexity: Hitting the Right Notes in Surgical IBD Care
  • When to Refer for IBD Surgery
    Erica R. Cohen, MD
    Identify appropriate timing for surgical referral in contemporary IBD management.
  • Management of the Ileal Pouch Anal Anastomosis
    Shannon Chang, MD, FACG
    Describe medical therapeutic options for the treatment of pouchitis and other pouch-related conditions.
  • The Latest and Greatest Surgery in IBD
    Jean Hearst Ashburn, MD
    Discuss current trends in IBD surgery including the role of early resection in ileal Crohn’s disease.
Bonus Session P: Anorectal Disorders
  • What to Do With Benign Anorectal Disorders
    Satish S.C. Rao, MD, FACG
    Recognize benign anorectal disorders and management options for anorectal ulcers, fissures, and hemorrhoids.
  • Anal Cancer Screening and Prevention
    Jessica D. Korman, MD
    Evaluate indications for anal cancer screening with evidence-based strategies for detection and prevention.
  • Competence Beyond the Scope: Inclusive Anal Care
    Victor G. Chedid, MD, MS
    Apply principles of inclusive, evidence-based anal care—including STI screening and management—to optimize clinical outcomes and patient-centered care for LGBTI populations.
View Wednesday Agenda